歌礼制药有限公司（股票名称：歌礼制药-B，股票代码：01672）于2026年10月26日发布翌日披露报表，披露当日股份回购相关事项。
\n\n公司当日通过香港联交所场内交易方式回购普通股合计10.00万股，占已发行股本约0.0095%。回购价格介乎每股5.47港元至5.84港元，合计支付约55.88万港元。
\n\n本次回购完成后，公司已发行股本（不包括库存股份）仍为1,052,202,859股，库存股份数量合计5,784,210股。公司于2026年6月29日获批准购回不超过106,137,084股股份，截至公告日，已累计回购股份总数为4,995,000股。公司确认，本次回购行为已遵守香港联合交易所有限公司证券上市规则及相关法规的规定。
\n\n公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.